These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

582 related items for PubMed ID: 32471368

  • 1. Associations of urological malignancies with renal progression and mortality in advanced chronic kidney disease: a propensity-matched cohort study.
    Chinnadurai R, Clarke NW, Kalra PA.
    BMC Nephrol; 2020 May 29; 21(1):202. PubMed ID: 32471368
    [Abstract] [Full Text] [Related]

  • 2. Cancer patterns and association with mortality and renal outcomes in non-dialysis dependent chronic kidney disease: a matched cohort study.
    Chinnadurai R, Flanagan E, Jayson GC, Kalra PA.
    BMC Nephrol; 2019 Oct 22; 20(1):380. PubMed ID: 31640599
    [Abstract] [Full Text] [Related]

  • 3. Advanced chronic kidney disease, end-stage renal disease and renal death among HIV-positive individuals in Europe.
    Ryom L, Kirk O, Lundgren JD, Reiss P, Pedersen C, De Wit S, Buzunova S, Gasiorowski J, Gatell JM, Mocroft A, EuroSIDA in EuroCoord.
    HIV Med; 2013 Sep 22; 14(8):503-8. PubMed ID: 23590641
    [Abstract] [Full Text] [Related]

  • 4. Progression and outcomes of non-dialysis dependent chronic kidney disease patients: A single center longitudinal follow-up study.
    Khan YH, Sarriff A, Adnan AS, Khan AH, Mallhi TH, Jummaat F.
    Nephrology (Carlton); 2017 Jan 22; 22(1):25-34. PubMed ID: 26718476
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Association between non-malignant monoclonal gammopathy and adverse outcomes in chronic kidney disease: A cohort study.
    Fenton A, Chinnadurai R, Gullapudi L, Kampanis P, Dasgupta I, Ritchie J, Harding S, Ferro CJ, Kalra PA, Taal MW, Cockwell P.
    PLoS Med; 2020 Feb 22; 17(2):e1003050. PubMed ID: 32109242
    [Abstract] [Full Text] [Related]

  • 9. Gout and the risk of advanced chronic kidney disease in the UK health system: a national cohort study.
    Stack AG, Johnson ME, Blak B, Klein A, Carpenter L, Morlock R, Maguire AR, Parsons VL.
    BMJ Open; 2019 Aug 28; 9(8):e031550. PubMed ID: 31462487
    [Abstract] [Full Text] [Related]

  • 10. Receipt of Nephrology Care and Clinical Outcomes Among Veterans With Advanced CKD.
    Fung E, Chang TI, Chertow GM, Thomas IC, Asch SM, Kurella Tamura M.
    Am J Kidney Dis; 2017 Nov 28; 70(5):705-714. PubMed ID: 28811048
    [Abstract] [Full Text] [Related]

  • 11. Longitudinal Weight Change During CKD Progression and Its Association With Subsequent Mortality.
    Ku E, Kopple JD, Johansen KL, McCulloch CE, Go AS, Xie D, Lin F, Hamm LL, He J, Kusek JW, Navaneethan SD, Ricardo AC, Rincon-Choles H, Smogorzewski M, Hsu CY, CRIC Study Investigators.
    Am J Kidney Dis; 2018 May 28; 71(5):657-665. PubMed ID: 29217305
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Association between Monocyte Count and Risk of Incident CKD and Progression to ESRD.
    Bowe B, Xie Y, Xian H, Li T, Al-Aly Z.
    Clin J Am Soc Nephrol; 2017 Apr 03; 12(4):603-613. PubMed ID: 28348030
    [Abstract] [Full Text] [Related]

  • 14. Predictive factors of rapid linear renal progression and mortality in patients with chronic kidney disease.
    Ali I, Chinnadurai R, Ibrahim ST, Green D, Kalra PA.
    BMC Nephrol; 2020 Aug 14; 21(1):345. PubMed ID: 32795261
    [Abstract] [Full Text] [Related]

  • 15. Sex Differences in the Progression of CKD Among Older Patients: Pooled Analysis of 4 Cohort Studies.
    Minutolo R, Gabbai FB, Chiodini P, Provenzano M, Borrelli S, Garofalo C, Bellizzi V, Russo D, Conte G, De Nicola L, Collaborative Study Group on the Conservative Treatment of CKD of the Italian Society of Nephrology.
    Am J Kidney Dis; 2020 Jan 14; 75(1):30-38. PubMed ID: 31409508
    [Abstract] [Full Text] [Related]

  • 16. Low HDL cholesterol as a predictor of chronic kidney disease progression: a cross-classification approach and matched cohort analysis.
    Kawachi K, Kataoka H, Manabe S, Mochizuki T, Nitta K.
    Heart Vessels; 2019 Sep 14; 34(9):1440-1455. PubMed ID: 30874893
    [Abstract] [Full Text] [Related]

  • 17. Association of kidney disease outcomes with risk factors for CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) study.
    Yang W, Xie D, Anderson AH, Joffe MM, Greene T, Teal V, Hsu CY, Fink JC, He J, Lash JP, Ojo A, Rahman M, Nessel L, Kusek JW, Feldman HI, CRIC Study Investigators.
    Am J Kidney Dis; 2014 Feb 14; 63(2):236-43. PubMed ID: 24182662
    [Abstract] [Full Text] [Related]

  • 18. Kidney, Cardiac, and Safety Outcomes Associated With α-Blockers in Patients With CKD: A Population-Based Cohort Study.
    Hundemer GL, Knoll GA, Petrcich W, Hiremath S, Ruzicka M, Burns KD, Edwards C, Bugeja A, Rhodes E, Sood MM.
    Am J Kidney Dis; 2021 Feb 14; 77(2):178-189.e1. PubMed ID: 32920153
    [Abstract] [Full Text] [Related]

  • 19. Fasting Urinary Osmolality, CKD Progression, and Mortality: A Prospective Observational Study.
    Tabibzadeh N, Wagner S, Metzger M, Flamant M, Houillier P, Boffa JJ, Vrtovsnik F, Thervet E, Stengel B, Haymann JP, NephroTest Study Group.
    Am J Kidney Dis; 2019 May 14; 73(5):596-604. PubMed ID: 30777634
    [Abstract] [Full Text] [Related]

  • 20. Association of symptoms of depression with progression of CKD.
    Tsai YC, Chiu YW, Hung CC, Hwang SJ, Tsai JC, Wang SL, Lin MY, Chen HC.
    Am J Kidney Dis; 2012 Jul 14; 60(1):54-61. PubMed ID: 22495469
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.